FDA Inspection 1172929 — Panacea Biotec Pharma Limited

Panacea Biotec Pharma Limited — FEI 3007187282

The FDA completed an inspection of Panacea Biotec Pharma Limited on June 8, 2022 in Solan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Solan (India)